- NCT Number Not Available
- Primary Citation
Trial Information
Generic NameEpoetin alfaProduct NamePROCRIT®Therapeutic AreaBlood and Lymph ConditionsEnrollment1302% Female38%% WhiteN/A
Product ClassColony-Stimulating FactorsSponsor Protocol NumberEPO-2 /// PR98-15-014Data PartnerJohnson & JohnsonCondition StudiedAnemia, Critical IllnessMean/Median Age (Years)51
Supporting Documentation
- Collected Datasets Available
- Data Definition Specification Available
- Protocol with Amendments Available
- Statistical Analysis Plan Available
- Clinical Study Report Available
Approved Data Requests Associated with this Trial
- 2024-0356 : Combining clinical trials with external data: applications in the YODA database
- 2023-5486 : Incorporating external data in clinical trial setting using BART
- 2023-5195 : Predictive modeling of adverse events and symptoms patterns in large scale clinical trials
- 2016-0960 : Bayesian Methods for Comparative Effectiveness Research
- 2016-0774 : Individual patient data meta-analysis of four multicenter, randomized, controlled trials evaluating epoetin alfa in critically ill trauma patients